Lista de obras - Johannes Streffer - Dominio Público Uruguay

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

scientific article published on 18 December 2019

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

artículo científico publicado en 2020

Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study

artículo científico publicado en 2012

Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.

artículo científico publicado en 2008

Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients

artículo científico publicado en 2020

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab

artículo científico publicado en 2018

Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform

artículo científico publicado en 2015

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

artículo científico publicado en 2019

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease

artículo científico publicado en 2020

Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease

artículo científico publicado en 2005

DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION

scholarly article by Sarah Westwood et al published July 2017 in Alzheimer's and Dementia

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

artículo científico publicado en 2020

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

artículo científico publicado en 2019

Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

artículo científico publicado en 2020

Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio

artículo científico publicado en 2015

Impaired trunk stability in individuals at high risk for Parkinson's disease

artículo científico publicado en 2012

Incidence of Creutzfeldt-Jakob disease in Switzerland

artículo científico publicado en 2002

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

artículo científico publicado en 2003

Inflammatory biomarkers in Alzheimer's disease plasma.

artículo científico publicado en 2019

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

scholarly article by Mara Ten Kate et al published 27 September 2018 in Alzheimers Research & Therapy

Making use of longitudinal information in pattern recognition

artículo científico publicado en 2016

Phenotypic variation of autosomal-dominant corticobasal degeneration

artículo científico publicado en 2012

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

scientific article published on 08 May 2019

Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease

scientific article published on 01 April 2019

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.

artículo científico publicado en 2018

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology

artículo científico publicado en 2017

The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers

artículo científico publicado en 2010

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

scientific article published on 01 January 2020

Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease

artículo científico publicado en 2011

Lista de obras de Johannes Streffer

A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study

Association between deposition of beta-amyloid and pathological prion protein in sporadic Creutzfeldt-Jakob disease.

Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients

Biomarker pattern of ARIA-E participants in phase 3 randomized clinical trials with bapineuzumab

Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease

Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease

DISCOVERY AND VALIDATION OF MULTIMODAL BIOMARKER SIGNATURES RELATING TO ALZHEIMER'S DISEASE PATHOLOGY AND PROGRESSION

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

Impact of cerebrospinal fluid matrix on the detection of Alzheimer's disease with Aβ42 and influence of disease on the total-Aβ42/Aβ40 ratio

Impaired trunk stability in individuals at high risk for Parkinson's disease

Incidence of Creutzfeldt-Jakob disease in Switzerland

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

Inflammatory biomarkers in Alzheimer's disease plasma.

MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study

Making use of longitudinal information in pattern recognition

Phenotypic variation of autosomal-dominant corticobasal degeneration

Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology

The time course of CO2 laser-evoked responses and of skin nerve fibre markers after topical capsaicin in human volunteers

Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort

Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease